发明名称 |
Deacetylase inhibitor therapy |
摘要 |
The present invention relates to deacetylase inhibitor (e.g., histone deacetylase inhibitor) therapies and demonstrates that individuals with low electrolyte levels may have increased susceptibility to certain unwanted side effects such as cardiac side effects. In some embodiments, the invention provides methods of administering DAC or DAC inhibitor therapy that includes electrolyte supplementation. |
申请公布号 |
US8957027(B2) |
申请公布日期 |
2015.02.17 |
申请号 |
US200711759471 |
申请日期 |
2007.06.07 |
申请人 |
Celgene Corporation |
发明人 |
McCulloch William;Piekarz Richard L.;Bates Susan E. |
分类号 |
A61K38/15;A61K33/00;A61K33/06;A61P35/00;A61K31/19 |
主分类号 |
A61K38/15 |
代理机构 |
Jones Day |
代理人 |
Jones Day |
主权项 |
1. A method for treating a Hodgkin lymphoma, myeloma, or myelodysplastic syndrome in a patient comprising intravenously administering to the patient a unit dose of romidepsin over a time period of over 30 to 60 minutes. |
地址 |
Summit NJ US |